Table 2.
Variable | pCR (%) | Univariate analysis | Multivariate analysis | ||
OR (95% CI) | P value | OR (95% CI) | P value | ||
Age | |||||
<50 | 8 (10.3) | 0.44 (0.145–1.33) | 0.147 | ||
>50 | 7 (20.6) | ||||
ER | |||||
Negative | 10 (25) | 4.46 (1.4–14.2) | 0.011 | 4.66 (1.46–14.81) | 0.0076 |
Positive | 5 (6.9) | ||||
PR | |||||
Negative | 13 (21.3) | 6.5 (1.39–30.36) | 0.017 | 1.88 (0.40–8.78) | 0.281 |
Positive | 2 (4) | ||||
HER2 | |||||
Negative | 9 (12.2) | ||||
Positive | 6 (15.8) | 1.35 (0.11–4.13) | 0.597 | ||
Grade | |||||
III | 10 (16.1) | 2.01 (0.59–6.89) | 0.262 | ||
I/II | 4 (8.7) | ||||
Tumor stage | |||||
T2 | 10 (17.8) | 2.21 (0.70–6.96) | 0.172 | ||
T3–4 | 5 (8.9) | ||||
Nodal status | |||||
N0 | 8 (19.1) | 2.05 (0.684–6.14) | 0.199 | ||
N+ | 7 (10.3) | ||||
MTUS1 level | |||||
Low | 8 (32) | 5.37 (1.71–16.84) | 0.0039 | 12.16 (3.88–38.07) | <0.0001 |
Medium/high (n = 7) | 7 (8.1) | ||||
Continuous* | 1.78 (1.19–2.76) | 0.005 |
Entered as continuous variable (probe set 212096_s_at values). Significant P values are indicated in bold.